Travelling Related Risks After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Referred from Countries with Destroyed Healthcare System to Transplant Center in Adjacent Country; A Single Center Survey

MLA

Basel Haffar, et al. “Travelling Related Risks After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Referred from Countries with Destroyed Healthcare System to Transplant Center in Adjacent Country; A Single Center Survey.” Clinical Lymphoma Myeloma and Leukemia, vol. 18, Sept. 2018, pp. S311–12. EBSCOhost, https://doi.org/10.1016/j.clml.2018.07.277.

APA

Basel Haffar, Jean El-Cheikh, Rita Nehme, Ali Bazerbachi, Radwan Massoud, Nour Moukalled, & Ammar Zahreddine. (2018). Travelling Related Risks After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Referred from Countries with Destroyed Healthcare System to Transplant Center in Adjacent Country; A Single Center Survey. Clinical Lymphoma Myeloma and Leukemia, 18, S311–S312. https://doi.org/10.1016/j.clml.2018.07.277

Chicago

Basel Haffar, Jean El-Cheikh, Rita Nehme, Ali Bazerbachi, Radwan Massoud, Nour Moukalled, and Ammar Zahreddine. 2018. “Travelling Related Risks After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Referred from Countries with Destroyed Healthcare System to Transplant Center in Adjacent Country; A Single Center Survey.” Clinical Lymphoma Myeloma and Leukemia 18 (September): S311–12. doi:10.1016/j.clml.2018.07.277.